Cipla Share Price: Stock 2 Saal Ke Low Par, US Business Ki Pareshaniyan Badhi!

HEALTHCAREBIOTECH
Whalesbook Logo
AuthorVihaan Mehta|Published at:
Cipla Share Price: Stock 2 Saal Ke Low Par, US Business Ki Pareshaniyan Badhi!
Overview

Bro, Cipla ka stock aaj **2%** gir gaya aur 2 saal ke sabse kam level par aa gaya, jabki BSE Sensex upar ja raha tha. US mein company ke business mein dikkat chal rahi hai, khaas kar gRevlimid aur Lanreotide supply mein. Profit kam ho raha hai kyunki margins tight ho gaye hain.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • ✓Quarterly Results
  • ✓Concall Announcements
  • ✓New Orders & Big Deals
  • ✓Capex Announcements
  • ✓Bulk Deals
  • ✦And much more
Add StocksGet it on Google PlayDownload on the App Store

Ab yeh US wala scene kya hai? Asal mein, company ko wahaan kuch bade products ki supply mein problem ho rahi hai, jisse unki sales affect ho rahi hai. Profitability bhi kam ho rahi hai kyunki unke margins dab rahe hain. India mein toh sales achhi hai, par jo US se achha paisa aata tha woh ab miss ho raha hai. Aage chal kar naye products launch karne padenge jo yeh revenue gap fill kar sakein.

Brokerage firms ki baat karein toh woh bhi filhaal thoda cautious hain. UBS ne 'Neutral' rating di hai aur ₹1,400 ka target diya hai, unhone kaha ki growth toh hai par supply hurdles bhi hain. Nomura/Instinet ne 'Buy' rating di hai aur target ₹1,510 rakha hai, unko lagta hai naye products se fayda ho sakta hai. HSBC ne 'Hold' karne ki salah di hai.

Basically, 36 analysts ka average target ₹1,436.58 hai, matlab current price se lagbhag 17% tak upar jaane ka potential hai. Lekin yeh sab tabhi hoga jab margins ki problem solve ho aur US market mein challenges handle ho paayein. Ab sabka dhyaan May 13, 2026 ko aane wale Q4 FY26 results par hai, jisme pata chalega ki company ke recovery plan ka kya scene hai.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Add Stocks
Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.